Axoft
PrivateLast Round
Series A
Apr 29, 2026
Total Funding Raised
$63M
Momentum Score
50 /100
Company Overview
Axoft is a neurotechnology company, founded in 2021 and headquartered in Cambridge, Massachusetts, that develops implantable Brain-Computer Interfaces (iBCIs). The company spun out of research from Harvard University and creates its implants from novel, ultra-soft, and flexible materials designed to mimic brain tissue, thereby reducing scarring and improving long-term stability. Axoft's technology aims to provide a seamless, high-resolution interface between the brain and electronics to treat a range of neurological disorders. The company has received FDA Breakthrough Device designation and began its first-in-human clinical trials in early 2025. Axoft has raised over $18 million in funding from investors including The Engine, Reform Ventures, and Decent Capital.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axoft Comps
Public and private peers based on sector, stage, and business model.
Axoft Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 29, 2026 | ||||
| Seed | Oct 18, 2022 |
Axoft Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Blindspot Ventures | Seed |
| Hillhouse Investment | Series A |
| Taihill Venture | Seed |
| Stanford President's Fund | Series A |
| Amino Capital | Seed |
| Safar Partners | Seed |
| AIBasis | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2026
Raised $55M led by C.P. Group Innovation.
- Apr 1, 2026
Introduced 'Fleuron polymers' product line, hiring chemist for development.
Axoft Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Axoft's valuation, stock price, and market status.
